DEFM14A: Sonida Senior Living to Acquire CNL Healthcare in $1.8B Deal
Merger Announcement
Sonida Senior Living will acquire CNL Healthcare Properties in a cash and stock transaction valued at approximately $1.8 billion, creating the eighth largest U.S. senior living owner.
Summary
- Sonida Senior Living (SNDA) will acquire CNL Healthcare Properties (CHP) through a series of mergers, with SNDA Merger Sub surviving, resulting in SNDA owning all of CHP's assets.
- Each share of CHP Common Stock will be converted into the right to receive $2.32 in cash and a number of SNDA Common Stock shares equal to $4.58 divided by SNDA's 10-day volume weighted average trading price (VWAP), subject to a collar of $22.73 to $34.76 per share.
- The total transaction consideration for CHP stockholders is approximately $6.90 per share.
- Affiliates of Conversant Capital LLC and Silk Partners, LP will invest approximately $110 million in SNDA through a private placement, receiving 4,113,688 shares of SNDA Common Stock at $26.74 per share.
- Post-transaction, pre-transaction SNDA stockholders (including investors in the equity financing) will hold between 39.5% and 50% of the combined company, while former CHP stockholders will hold between 50% and 60.5%.
- SNDA will incur approximately $900 million in additional indebtedness, leading to a total consolidated indebtedness of approximately $1.6 billion, with deleveraging from low-9x to midto upper-7x net debt to EBITDA.
- SNDA stockholders will vote on increasing authorized common stock from 30 million to 100 million shares, approving the stock issuance to CHP stockholders and investors, and amendments to SNDA's charter regarding advance notice and indemnification.
- CHP stockholders will vote on approving the transactions, electing five director nominees, and ratifying the independent auditor for fiscal year 2025.
- Certain affiliates of Conversant, holding approximately 52.6% of SNDA's voting stock, have entered into a voting agreement to approve the authorized share increase, stock issuance, and adjournment proposals, ensuring their passage.
Sentiment
Score: 8
Explanation: The sentiment is highly positive due to the strategic nature of the acquisition, significant expected synergies, improved financial leverage for SNDA, and the provision of liquidity to CHP stockholders. While standard merger risks and dilution are present, the overall tone and detailed plans suggest a strong belief in the transaction's success and value creation.
Positives
- The transaction creates the eighth largest owner of U.S. senior living assets, with approximately 14,700 units, enhancing market presence and geographic footprint.
- Expected annual cost synergies of $16 million to $20 million are anticipated within one year of closing, along with future operating synergies from SNDA's sales, marketing, and operational capabilities.
- The combined company is expected to have an increased equity market capitalization (approximately 500% increase in SNDA's free float to $1.0 billion), improved trading liquidity, and better access to capital.
- SNDA's balance sheet is expected to strengthen, improving borrowing costs and accelerating the path to a medium-term leverage target of 6x net debt to EBITDA.
- CHP stockholders receive immediate partial cash liquidity ($2.32 per share) and unrestricted, freely tradable SNDA Common Stock, offering continued investment in the combined entity with liquidity.
- The transaction consideration of $6.90 per share represents a premium to CHP's most recently announced estimated NAV per share of $6.64.
Negatives
- SNDA's current stockholders will experience dilution due to the issuance of between 22.9 million and 35.0 million new SNDA Common Stock shares to former CHP holders and 4,113,688 shares to investors.
- The market price of SNDA Common Stock may decline due to the significant increase in outstanding shares and potential sales by former CHP stockholders.
- The value of the stock consideration for CHP stockholders is subject to market fluctuations of SNDA Common Stock, with a collar mechanism that limits upside if SNDA's VWAP exceeds $34.76.
- Significant transaction costs are expected, which may exceed initial estimates and will be incurred regardless of whether the transactions are completed.
- Integration of the two companies may present material challenges, including diversion of management attention, difficulty retaining key employees, and unforeseen expenses.
Risks
- The transactions are subject to various conditions, including stockholder and regulatory approvals, which may not be satisfied or waived in a timely manner or at all, leading to adverse effects on both companies.
- Failure to complete the transactions could result in SNDA or CHP being required to pay termination fees ($30 million each) or expense reimbursements (up to $10 million for SNDA).
- The Merger Agreement contains provisions limiting CHP's ability to pursue alternative transactions and could discourage third-party offers.
- Regulatory authorities may impose conditions on approvals that could adversely affect the combined company or delay/prevent completion.
- Uncertainties associated with the transactions may lead to a loss of management personnel, key employees, residents, suppliers, and other business partners.
- Potential litigation from purported stockholders alleging misleading disclosures could result in substantial costs or an injunction preventing completion.
- The unaudited pro forma financial information is for illustrative purposes only and may not reflect the actual operating results and financial condition of the combined company.
- CHP stockholders will incur a taxable event upon the exchange of their shares, and may not receive sufficient cash to cover tax obligations.
- The rights of CHP stockholders will change upon becoming SNDA stockholders due to differences in governing laws and corporate documents.
- SNDA's increased indebtedness post-transaction (approximately $1.6 billion) may reduce financial flexibility and increase borrowing costs, and financing arrangements contain restrictive covenants.
Future Outlook
The combined company is expected to become the eighth largest owner of U.S. senior living assets, with a focus on high-quality assets in strategic regional markets. Management anticipates achieving $16-20 million in annual cost synergies within one year, strengthening the balance sheet, improving borrowing costs, and accelerating deleveraging to a medium-term target of 6x net debt to EBITDA. The transaction is expected to enhance operational control and capital allocation through a unified owner-operator-investor model, with thoughtful evaluation of dispositions in low-growth, non-strategic markets.
Management Comments
- The SNDA Board and the CHP Board believe that the Transactions will provide a number of significant potential strategic opportunities and benefits that will be in the best interest of their respective stockholders.
- Brandon M. Ribar (SNDA CEO): 'The SNDA Board unanimously recommends that holders of SNDA Stock vote FOR the Authorized Share Increase Proposal, FOR the Stock Issuance Proposal, FOR the Advance Notice Proposal, FOR the Indemnification Proposal and FOR the SNDA Adjournment Proposal (if presented at the SNDA Special Meeting).'
- James M. Seneff, Jr. (CHP Chairman) and Stephen H. Mauldin (CHP CEO): 'We join the CHP Board in its recommendations and look forward to the successful completion of the Transactions.'
- CHP management believes that the proposed terms of the structured investment from Company F were onerous, costly, and one-sided, and therefore were not in the best interests of CHP and its stockholders.
- CHP management determined that a transaction with Company E would create a pro forma entity with leverage levels deemed too high to achieve near-term liquidity for CHP stockholders.
Industry Context
The senior living industry experienced material negative impacts from the COVID-19 pandemic, affecting occupancy, revenues, and cost structures. While the market for seniors housing properties began to stabilize in 2021, pricing transparency and financing for larger transactions remained challenging. This merger represents a strategic consolidation in a recovering market, aiming to leverage scale and operational efficiencies to navigate ongoing challenges like elevated labor costs and interest rate volatility. The combined entity will be a significant player, focusing on up-market and mid-market communities.
Comparison to Industry Standards
- KeyBanc Capital Markets (KBCM) conducted a comparable public companies analysis for CHP, including REITs focused on senior healthcare assets (Omega Healthcare Investors, American Healthcare REIT, CareTrust REIT, Sabra Health Care REIT, National Health Investors, LTC Properties) with a median implied nominal capitalization rate of 6.6%.
- KBCM applied an illiquidity and sizing discount of 15% to CHP's valuation to reflect its non-traded nature and portfolio size relative to publicly-traded comparable companies.
- KBCM's precedent portfolio transactions analysis for senior housing assets (transactions >$400M closed in the last five years) showed a median price per unit of $202,867 and a median capitalization rate of 6.8%.
- RBC Capital Markets (RBC CM) performed a selected public companies analysis for SNDA, comparing it to American Healthcare REIT, Brookdale Senior Living Inc., Ventas Inc., and Welltower Inc., observing calendar year 2026 estimated FFO multiples of 19.7x to 30.5x and EBITDA multiples of 14.1x to 28.8x.
- RBC CM noted that SNDA's historical trading volumes have been relatively low compared to other publicly-traded companies, and applied a 15% illiquidity and sizing discount in its analysis.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director and Chairperson of SNDA Board | NA | Michael Simanovsky (Conversant's Managing Partner) | Second Merger Effective Time | Designation by Conversant Fund A as part of A&R Investor Rights Agreement. |
| Director of SNDA Board | NA | Stephen H. Mauldin (CHP CEO and President) | Second Merger Effective Time | Designation by CHP as part of Merger Agreement. |
| Director of SNDA Board | NA | One additional individual designated by CHP | Second Merger Effective Time | Designation by CHP as part of Merger Agreement, subject to SNDA Board's Nominating and Corporate Governance Committee approval. |
| Director of SNDA Board | Elliott R. Zibel | NA | Second Merger Effective Time | Step down as part of SNDA Board re-composition following the merger. |
| Director of SNDA Board | David W. Johnson | NA | Second Merger Effective Time | Step down as part of SNDA Board re-composition following the merger. |
| Director of SNDA Board | One designee of Silk | NA | Second Merger Effective Time | Step down as part of SNDA Board re-composition following the merger. |
| Chief Executive Officer of SNDA | NA | Brandon Ribar (Current SNDA CEO) | Post-Transaction | Continued service in current role. |
| Executive Officers of SNDA | NA | Current SNDA executive officers | Post-Transaction | Continued service in current roles. |
| Executive Officers of SNDA | CHP executive officers | NA | Post-Transaction | None of CHP executive officers are expected to become executive officers of SNDA. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorized Share Capital Increase | SNDA's authorized common stock will increase from 30,000,000 to 100,000,000 shares, subject to stockholder approval. | Promptly after SNDA Special Meeting approval | Enables SNDA to issue shares for the acquisition and future capital needs, but dilutes existing stockholders' ownership percentage. |
| Advance Notice Provisions Amendment | SNDA Charter will be amended to move advance notice procedures for stockholder nominations and business proposals from the Charter to the Bylaws. | Promptly after SNDA Special Meeting approval | Promotes clarity, flexibility, and good corporate governance by allowing the SNDA Board to adapt more quickly to evolving legal requirements and best practices. |
| Indemnification and Expense Advancement Limitations | SNDA Charter will be amended to include customary limitations on indemnification and expense advancement for directors and officers, requiring a written undertaking to repay expenses if not entitled to indemnification and limiting obligations for director/officer-initiated proceedings unless authorized by the Board. | Promptly after SNDA Special Meeting approval | Promotes responsible stewardship of corporate resources while safeguarding directors' and officers' rights for good faith actions, discouraging unauthorized litigation. |
| Board Composition | SNDA Board will include two directors designated by CHP (including Stephen H. Mauldin) and Michael Simanovsky (Conversant's Managing Partner) as Chairperson, joining two other Conversant designees. Three current SNDA directors will step down. | Second Merger Effective Time | Reflects the new ownership structure and investor influence, potentially bringing new perspectives and expertise to the board, but reducing the influence of pre-transaction SNDA stockholders. |
| Voting Rights Agreement | Certain Conversant affiliates, holding 52.6% of SNDA's voting stock, entered a Voting Agreement to vote in favor of key merger-related proposals and grant an irrevocable proxy to CHP. | November 4, 2025 | Ensures the passage of critical SNDA stockholder proposals, reducing uncertainty for the transaction's completion. |
| Investor Rights Agreement (A&R) | Conversant Fund A will have rights to designate 1-3 directors based on beneficial ownership, designate the SNDA Board chairperson, and consent rights over certain fundamental business changes. Silk will have rights to designate one director. Certain standstill provisions apply to Conversant Parties and Silk for 18 months. | Equity Financing Closing | Formalizes significant governance influence for major investors, potentially impacting strategic decisions and board independence, but also providing stability and alignment with key capital providers. |
Legal Proceedings
- As of January 1, 2026, SNDA and CHP have received letters from counsel representing purported stockholders of SNDA alleging that the registration statement on Form S-4 is materially misleading and/or omits purportedly material information, demanding corrective disclosures. SNDA and CHP believe such allegations are without merit.
Related Party Transactions
- Certain affiliates of Conversant Capital LLC and Silk Partners, LP, two of the largest beneficial owners of SNDA Stock, will invest approximately $110 million in SNDA in exchange for 4,113,688 shares of SNDA Common Stock in a private placement.
- CHC (CNL Healthcare Corp.), CHP's external manager and advisor, and SNDA have entered into a Transition Services Agreement (TSA) and an Asset Purchase and Sale Agreement (APA).
- Under the TSA, CHC will be reimbursed for costs of providing certain transition services to SNDA for up to one year post-closing.
- Under the APA, CHC is selling certain assets (asset management database, books, records, intellectual property) used in its advisory functions to SNDA for $5 million, plus approximately $1.075 million for retention bonuses to CHC employees.
- SNDA will offer full-time employment to no fewer than 17 CHC employees for at least 90 days, assuming certain severance payments of approximately $1.1 million.
- Certain investment entities affiliated with Conversant, holding approximately 52.6% of SNDA's voting stock, entered into a Voting Agreement with CHP to vote in favor of key SNDA proposals and grant an irrevocable proxy.
- The A&R Investor Rights Agreement grants Conversant Fund A and Silk certain board designation and governance rights, including the right for Conversant Fund A to designate the SNDA Board chairperson and consent rights over certain fundamental business changes.
- The A&R Registration Rights Agreement provides Conversant Parties and Silk Parties with demand and piggyback registration rights for their SNDA equity securities.
Stakeholder Impact
- **Shareholders (CHP):** Will receive a combination of cash and SNDA Common Stock, providing immediate liquidity and continued investment in a larger, more diversified company. However, they will have reduced ownership and voting influence in the combined entity and will not have appraisal rights.
- **Shareholders (SNDA):** Will experience dilution from the issuance of new shares but are expected to benefit from increased scale, diversification, cost synergies, and improved financial metrics (e.g., deleveraging, better access to capital).
- **Employees (CHC):** Certain employees of CHC will be offered employment with SNDA, ensuring continuity for some personnel.
- **Management (SNDA):** Current SNDA executive officers, including the CEO, are expected to continue in their roles, with new directors from CHP and Conversant joining the board, potentially altering board dynamics.
- **Management (CHP):** CHP's executive officers are not expected to become SNDA executive officers, but Stephen H. Mauldin will join the SNDA Board, providing some continuity of representation.
- **Customers/Residents:** The combination aims to enhance operational control and capital allocation, potentially leading to improved services or stability in senior living communities.
- **Suppliers/Vendors:** Relationships may be affected by the merger, with potential for renegotiation or termination of contracts, though SNDA aims to maintain significant relationships.
- **Creditors:** SNDA's increased indebtedness and new financing arrangements will impact its credit profile, though deleveraging is expected to improve borrowing costs over time.
Next Steps
- SNDA to hold a special meeting of stockholders (SNDA Special Meeting) on February 26, 2026, to vote on the Authorized Share Increase Proposal, Stock Issuance Proposal, Advance Notice Proposal, Indemnification Proposal, and SNDA Adjournment Proposal.
- CHP to hold an annual meeting of stockholders (CHP Annual Meeting) on March 6, 2026, to vote on the Transactions Proposal, Director Election Proposal, Auditor Ratification Proposal, and CHP Adjournment Proposal.
- SNDA and CHP will use commercially reasonable efforts to hold their respective stockholder meetings on the same date.
- SNDA will file a certificate of amendment to its Charter to increase authorized common stock from 30 million to 100 million shares, effective promptly after SNDA Special Meeting approval.
- SNDA will cause the shares of SNDA Common Stock to be issued in connection with the Equity Purchase to be approved for listing on the NYSE.
- CHP will cause each member of its Board and officers to resign, effective immediately prior to the Second Merger Effective Time.
- SNDA will appoint two individuals designated by CHP (including Stephen H. Mauldin) to the SNDA Board, subject to approval by SNDA's Nominating and Corporate Governance Committee.
- Conversant Fund A expects to designate Michael Simanovsky as Chairperson of the SNDA Board, joining two other Conversant designees, with three current SNDA directors stepping down.
- The Equity Purchase Closing and First Merger are expected to occur five business days after all conditions are met, but not before March 4, 2026.
- The Second Merger is expected to occur on the business day following the First Closing Date.
- Parent will prepare a written allocation of the purchase price for U.S. federal income tax purposes within 90 days after the Second Closing Date.
Key Dates
| Date | Description |
|---|---|
| 2017 | CHP began evaluating strategic alternatives to provide liquidity to its stockholders. |
| April 3, 2018 | CHP Board formed the CHP Special Committee to consider strategic alternatives. |
| July 11, 2018 | CHP suspended its distribution reinvestment plan and stock redemption plan. |
| May 15, 2019 | CHP completed the sale of 55 medical office and related properties for approximately $1.25 billion. |
| April 2019 | CHP sold an additional portfolio of four inpatient rehabilitation facilities for $94 million. |
| May 21, 2019 | CHP Board authorized a special cash distribution of $2.00 per share to stockholders. |
| October 2019 | CHP began selling the balance of its post-acute and acute hospital holdings. |
| August 2022 | CHP completed the sale of the last of its post-acute and acute hospital holdings. |
| January 1, 2023 | Start of period for certain SEC filings and financial statement reviews. |
| June 8, 2023 | CHP's Expense Support Agreement with its Advisor was terminated. |
| December 7, 2023 | SNDA entered into an amended and restated credit agreement (Company Existing Credit Agreement). |
| March 10, 2025 | CHP Board announced an estimated NAV per share range of $6.33 to $6.98, with a midpoint of $6.64. |
| April 4, 2025 | CHP and SNDA entered into a confidentiality agreement. |
| May 7, 2025 | CHP renewed its Advisory Agreement with its Advisor for a one-year term ending June 30, 2026. |
| June 15, 2025 | CHP and SNDA entered into a confidentiality agreement regarding SNDA information. |
| September 2, 2025 | CHP and SNDA executed a non-binding letter of intent. |
| September 30, 2025 | Balance sheet date for unaudited pro forma financial statements; SNDA's updated projections shared with CHP. |
| October 30, 2025 | Date for outstanding shares and awards for SNDA and CHP capital structure. |
| November 4, 2025 | Merger Agreement, Voting Agreement, Investment Agreements, APA, and TSA were executed. RBC Capital Markets and KeyBanc Capital Markets delivered fairness opinions. Last full trading day before public announcement of Merger Agreement. |
| November 5, 2025 | SNDA and CHP issued a joint press release announcing the execution of the Merger Agreement. |
| December 4, 2025 | Notification made to the Indiana Office of the Attorney General regarding regulatory approvals. |
| December 10, 2025 | SNDA Board unanimously approved an amendment to the SNDA Bylaws regarding advance notice requirements. |
| December 29, 2025 | SNDA entered into an amended and restated credit agreement for permanent debt facilities. |
| December 30, 2025 | Record date for SNDA Special Meeting and CHP Annual Meeting. Last practicable trading day prior to mailing of joint proxy statement/prospectus. |
| December 31, 2025 | Last practicable trading day prior to mailing of joint proxy statement/prospectus. |
| January 1, 2026 | SNDA and CHP received letters from counsel representing purported stockholders alleging misleading registration statement. |
| January 6, 2026 | Joint proxy statement/prospectus dated and first mailed to stockholders. |
| February 19, 2026 | Deadline for SNDA stockholders to request documents before the SNDA Special Meeting. |
| February 26, 2026 | SNDA Special Meeting to be held virtually. |
| February 27, 2026 | Deadline for CHP stockholders to request documents before the CHP Annual Meeting. |
| March 4, 2026 | Earliest date for Equity Purchase Closing without Parent's prior written consent. |
| March 6, 2026 | CHP Annual Meeting to be held in person. |
| May 29, 2026 | Outside Date for consummation of the Equity Purchase Closing. |
| H1 2026 | Expected closing timeframe for the Transactions. |
| November 6, 2026 | Deadline for CHP stockholders to provide notice for director nominees for the 2027 annual meeting, if the Transactions are not consummated. |
| November 3, 2026 | Expiration date for Conversant Warrants. |
| 2027 | Term for SNDA Class III directors expires. |
| 2028 | Term for SNDA Class I directors expires. |
| November 3, 2028 | Date after which SNDA Series A Preferred Stock is redeemable at 100% of liquidation preference. |
| 2029 | SNDA's 2029 annual meeting of stockholders, relevant for beneficial ownership thresholds for board designation rights. |
Recommendation
buyThe acquisition of CNL Healthcare Properties by Sonida Senior Living is a transformative event that is highly likely to be accretive to SNDA's long-term value. The creation of the eighth largest U.S. senior living owner significantly enhances scale, geographic diversification, and market positioning. The projected $16-20 million in annual cost synergies and the expected deleveraging of SNDA's net debt to EBITDA from low-9x to midto upper-7x are strong indicators of improved financial health and operational efficiency. While dilution for existing SNDA shareholders is a factor, the strategic benefits, including better access to capital and a unified owner-operator-investor model, are compelling. The premium paid for CHP shares relative to its NAV, combined with the secured financing and strong investor backing (Conversant/Silk), suggests confidence in the future performance of the combined entity. The unanimous board approvals and the voting agreement further de-risk the transaction's completion. This strategic move positions SNDA for enhanced growth and profitability in the recovering senior living sector, making it an attractive 'buy' for long-term investors.
Keywords
Merger, Acquisition, Senior Living, Healthcare Properties, REIT, Stock Exchange, Equity Financing, Debt Financing, Synergies, Corporate Governance, SEC Filing, Proxy Statement, Stockholder Vote, Real Estate
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.